Commission Actions

The Federal Trade Commission today announced a settlement with a California-based company that marketed a so-called breast enhancement product, "The Isis System." According to the FTC complaint, the...

The Commission has approved the filing of comments with the U.S. Food and Drug Administration regarding the availability of the 30-month stay of FDA approval of generic drug applications and revised...

According to the letter, signed by FTC Chairman Timothy J. Muris and Acting Assistant Attorney General for Antitrust R. Hewitt Pate, the proposed model definition would prevent non-lawyers from...

The Federal Trade Commission will host a public workshop on February 19 and 20, 2003, to explore how public and private sector entities, including businesses, industry associations, and consumer...

The Commission has authorized the staff to file comments with the U.S. Food and Drug Administration (FDA) concerning trans fatty acids in nutrition labeling. The comment, which is available on the FTC...

Consent Order Will Preserve Competition in Markets for Certain General Anesthetics, Neuromuscular Blocking Agents, Antiemetics, and New Injectable Iron Replacement Therapies Under the terms of a...

Nearly 28,000 borrowers will start receiving compensation checks this week from an initial redress pool of almost $45 million that resulted from an FTC settlement with home mortgage lender First...